U.K. Pharmaceuticals & Biotech High Insider Buying

GSK

Market Cap: UK£73.6b

Engages in the research, development, and manufacture of vaccines, specialty medicines, and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally.

Hikma Pharmaceuticals

Market Cap: UK£3.3b

Develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products.

Oxford Biomedica

Market Cap: UK£726.8m

A contract development and manufacturing organization, focuses on delivering therapies to patients worldwide.

PureTech Health

Market Cap: UK£295.3m

Engages in the development and commercialization of biotechnology and pharmaceutical solutions in the United States.

Animalcare Group

Market Cap: UK£164.3m

Develops, sells, and distributes licensed veterinary pharmaceuticals, and services for companion and production animals, and equine veterinary markets.

Diaceutics

Market Cap: UK£118.0m

A diagnostic commercialization company, provides data, data analytics, and implementation services for pharma and biotech companies.

4basebio

Market Cap: UK£99.1m

Engages in the research, development, manufacturing, and commercialization of synthetic DNA and RNA products, and non-viral vector solutions in Europe, the United States, and internationally.

Bioventix

Market Cap: UK£88.8m

Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide.

ECO Animal Health Group

Market Cap: UK£72.2m

ECO Animal Health Group plc, together with its subsidiaries, manufactured and supply animal health products internationally.

OptiBiotix Health

Market Cap: UK£7.0m

A life sciences company, engages in the discovery and development of microbiome modulation products in the United Kingdom, the United States, India, China, and internationally.